If you are interested in showcasing your company’s services to senior clinical development executives from Chinese and US BioPharmas, please contact: email@example.com.
Fountain Medical Development Limited is a global Contract Research Organization that is able to provide Clinical Development services of the ICH standards, and is engaged in delivery of high-quality and one-stop services in Clinical Research to Pharmaceuticals and Medical Device companies from abroad and China, including Regulatory Affairs, Medical Affairs, Clinical Operations, Data Management, Biostatistics, Pharmacovigilance and third-party audits. FMD is the first CRO that can provide joint drug development services in China and simultaneously in the US, Europe, Japan, Australia and Taiwan.
HLT is a leading medical AI company dedicated to transforming the relationship between humans and diseases. HLT has in-depth cooperation with regulators, universities and research institutes in China and other countries. Full lifecycle solutions of HLT, including clinical trials, post-launch development of drugs, product launch and real-world studies, significantly accelerate the process of new drug development. In addition, HLT's reports based on real-world insights have been published in The Lancet Oncology, Nature Medicine and other top journals. For more information, visit www.hltpharma.com.